Stem cell research promises to provide new therapies, preventive measures and even cures for some major human diseases and disorders. But some policymakers, like many Americans, have deep misgivings about the use of human embryonic tissue for this purpose. A panel talks about the therapeutic potential of stem cells, the ethical issues raised by the work, and federal funding for the research.

Guests

  • Dr. David Prentice of Do No Harm: Coalition of Americans for Research Ethics
  • Dr. Robert Goldstein chief scientific officer for the Juvenile Diabetes Foundation International
  • Rick Weiss science reporter for "The Washington Post"

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Readers’ Review: “Drown” by Junot Diaz

Wednesday, Jun 29 2016For this month's Readers' Review: "Drown" -- the debut collection of short stories by Pulitzer Prize-winning writer Junot Diaz. Twenty years ago, Diaz published ten heart-breaking tales about a fragmented family from the Dominican Republic finding their way in 1980s America.

What Brexit Means For The U.S.

Tuesday, Jun 28 2016With a now-likely U.K. exit from the EU, America’s relationship with a key intelligence and global trade ally will change. Please join us to discuss what the British vote means for the U.S. economy, the 2016 presidential campaign and global security.